MALIGNANT MIDDLE CEREBRAL ARTERY SYNDROME

This adverse event was reported 5 times

These drugs are most commonly taken by patients reporting MALIGNANT MIDDLE CEREBRAL ARTERY SYNDROME:

# Drug Count
0 TENECTEPLASE 2
1 BECLOMETHASONE DIPROPIONATE 1
2 DULOXETINE 1
3 DULOXETINE HYDROCHLORIDE 1
4 SACUBITRIL AND VALSARTAN 1
5 TIRZEPATIDE 1
6 WARFARIN 1
See all common drugs associated with MALIGNANT MIDDLE CEREBRAL ARTERY SYNDROME

MALIGNANT MIDDLE CEREBRAL ARTERY SYNDROME is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TENECTEPLASE 2 0.0013
1 BECLOMETHASONE DIPROPIONATE 1 0.0002
2 DULOXETINE HYDROCHLORIDE 1 0.0000
3 SACUBITRIL AND VALSARTAN 1 0.0000
4 WARFARIN 1 0.0000
5 TIRZEPATIDE 1 0.0000
See all drugs enriched for association with MALIGNANT MIDDLE CEREBRAL ARTERY SYNDROME

These drug classes are most commonly taken by patients reporting MALIGNANT MIDDLE CEREBRAL ARTERY SYNDROME:

# Drug class Count
0 Angiotensin 2 Receptor Blocker [EPC] 1
1 GLP-1 Receptor Agonist [EPC] 1
2 Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC] 1
See all common drug classes associated with MALIGNANT MIDDLE CEREBRAL ARTERY SYNDROME

MALIGNANT MIDDLE CEREBRAL ARTERY SYNDROME is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Angiotensin 2 Receptor Blocker [EPC] 1 0.0000
1 GLP-1 Receptor Agonist [EPC] 1 0.0000
See all drug classes enriched for association with MALIGNANT MIDDLE CEREBRAL ARTERY SYNDROME